Analyst Ratings for Vir Biotechnology (VIR)
VIR Rating Summary
VIR Price Target Summary
- Highest: $95.00 (H.C. Wainwright)
- Lowest: $12.00 (Morgan Stanley)
- Average: $32.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$32.71 (+237.6%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Avg. $ Target:
$32.71 (+237.6%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2023 | BofA Securities | Geoff Meacham | Downgrade | Neutral (Buy) |
14.00 (23.00) |
11.56 (9.69) |
-16.18% | Details |
| 3/6/2023 | JPMorgan » Updated 7/21/2023 |
Eric Joseph | Upgrade | Overweight (Neutral) |
24.00 (34.00) |
22.61 (9.69) |
-57.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
